Details Consolidated financial statements for the period ended 30 June 2024Consolidated Financial Statements results, Results CenterBy Rameda Admin13 أغسطس، 2024
Rameda Announces Price Increase Approvals for All Its Top Products Corporate NewsBy Rameda Admin7 أغسطس، 2024
Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance Corporate NewsBy Rameda Admin28 مايو، 2024
